CH585712A5 - - Google Patents
Info
- Publication number
- CH585712A5 CH585712A5 CH584176A CH584176A CH585712A5 CH 585712 A5 CH585712 A5 CH 585712A5 CH 584176 A CH584176 A CH 584176A CH 584176 A CH584176 A CH 584176A CH 585712 A5 CH585712 A5 CH 585712A5
- Authority
- CH
- Switzerland
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/252,030 US4304907A (en) | 1972-05-10 | 1972-05-10 | Bicyclo lactone intermediates for prostaglandin analogs |
US05/426,058 US4303796A (en) | 1972-05-10 | 1973-12-19 | 16-Phenoxy prostaglandin F2α analogs |
Publications (1)
Publication Number | Publication Date |
---|---|
CH585712A5 true CH585712A5 (xx) | 1977-03-15 |
Family
ID=26941978
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH668973A CH585711A5 (xx) | 1972-05-10 | 1973-05-10 | |
CH584176A CH585712A5 (xx) | 1972-05-10 | 1973-05-10 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH668973A CH585711A5 (xx) | 1972-05-10 | 1973-05-10 |
Country Status (8)
Country | Link |
---|---|
US (8) | US4304907A (xx) |
AU (1) | AU470415B2 (xx) |
BE (1) | BE799372A (xx) |
CH (2) | CH585711A5 (xx) |
DE (1) | DE2322673A1 (xx) |
FR (1) | FR2184007B1 (xx) |
GB (3) | GB1409843A (xx) |
NL (1) | NL7306462A (xx) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3864387A (en) * | 1973-05-21 | 1975-02-04 | Upjohn Co | 5-Oxa phenyl-and phenoxy-substituted prostaglandin F{HD 1{301 {0 {B analogs |
GB1502610A (en) * | 1974-12-12 | 1978-03-01 | Ici Ltd | Process for the preparation of prostaglandin intermediate |
GB1538871A (en) * | 1975-01-24 | 1979-01-24 | Lepetit Spa | Prostaglandins |
US4032561A (en) * | 1975-05-27 | 1977-06-28 | The Upjohn Company | 17-Phenyl-18,19,20-trinor-cis-4,5-didehydro-PGF1.sub.α compounds |
DE2655004C3 (de) * | 1976-12-02 | 1980-06-19 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Herstellung von bicyclischen Laktonen |
US4149006A (en) * | 1977-01-24 | 1979-04-10 | G. D. Searle & Co. | Prostaglandin derivatives having alkynyl, hydroxy and aryloxy junctions in the 2β side chain |
EP0096097B1 (en) * | 1982-06-15 | 1985-12-27 | International Business Machines Corporation | Method and apparatus for controlling access to a communication network |
US4600785A (en) * | 1983-12-22 | 1986-07-15 | Syntex (U.S.A.) Inc. | Processes and intermediates for making 16-phenoxy and 16-substituted phenoxy-prostatrienoic acid derivatives |
US4804787A (en) * | 1983-12-22 | 1989-02-14 | Syntex (U.S.A.) Inc. | Processes and intermediates for making 16-phenoxy and 16-substituted phenoxy-prostatrienoic acid derivatives |
US4912235A (en) * | 1983-12-22 | 1990-03-27 | Syntex (U.S.A.) Inc. | Processes and intermediates for making 16-phenoxy- and 16-substituted phenoxy-prostatrienoic acid derivatives and their stereoisomers |
US4929740A (en) * | 1984-10-09 | 1990-05-29 | Syntex (U.S.A.) Inc. | Process for making 16-phenoxy- and 16-(substituted phenoxy)-prostatrienoic acid derivatives |
US4778904A (en) * | 1985-09-13 | 1988-10-18 | Syntex (U.S.A.) Inc. | Intermediates for making 16-phenoxy- and 16-(substituted phenoxy)-prostatrienoic acid derivatives |
US4755531A (en) * | 1986-08-11 | 1988-07-05 | Syntex (U.S.A.) Inc. | Thiol esters of 4,5-allenyl prostaglandins and use thereof as antigastric secretion agents |
CS264861B1 (en) * | 1986-12-12 | 1989-09-12 | Kral Josef | Agent for cow natality increase |
US5296504A (en) * | 1988-09-06 | 1994-03-22 | Kabi Pharmacia | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
US6187813B1 (en) | 1990-04-10 | 2001-02-13 | Pharmacia & Upjohn Aktiebolag | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
EP0569046B1 (en) * | 1988-09-06 | 2002-11-13 | Pharmacia Aktiebolag | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
US5321128A (en) * | 1988-09-06 | 1994-06-14 | Kabi Pharmacia Ab | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
JP3097145B2 (ja) * | 1991-02-27 | 2000-10-10 | 日産化学工業株式会社 | コーリーラクトンジオールの光学分割方法 |
EP0638605B1 (en) * | 1993-08-10 | 1998-12-09 | Shin-Etsu Chemical Co., Ltd. | Process for preparing a polyester-modified silicone resin and a curable composition comprising the polyester-modified silicone resin |
US20020037914A1 (en) | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
US9241918B2 (en) | 2005-03-16 | 2016-01-26 | Allergan, Inc. | Enhanced bimatoprost ophthalmic solution |
US7851504B2 (en) | 2005-03-16 | 2010-12-14 | Allergan, Inc. | Enhanced bimatoprost ophthalmic solution |
US8623918B2 (en) | 2008-10-29 | 2014-01-07 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
US8722739B2 (en) | 2008-10-29 | 2014-05-13 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
US20110293549A1 (en) | 2009-02-03 | 2011-12-01 | Athena Cosmetics, Inc. | Composition, method and kit for enhancing hair |
WO2010108012A1 (en) * | 2009-03-18 | 2010-09-23 | Duke University | Compositions and methods for promoting nasal patency and treating neurogenic bladder using prostaglandins |
US9522153B2 (en) | 2009-12-22 | 2016-12-20 | Allergan, Inc. | Compositions and methods for lowering intraocular pressure |
SG183498A1 (en) * | 2010-02-25 | 2012-09-27 | Abt Holding Co | Modulation of angiogenesis |
US20110206647A1 (en) * | 2010-02-25 | 2011-08-25 | Abt Holding Company | Modulation of Angiogenesis |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3505386A (en) * | 1965-12-29 | 1970-04-07 | Upjohn Co | Compounds related to prostaglandins |
US3711528A (en) * | 1970-04-06 | 1973-01-16 | Upjohn Co | Racemic dihydro-pge{11 {11 and related compounds |
US3711515A (en) * | 1970-11-27 | 1973-01-16 | Upjohn Co | Tricyclic lactone alkene or alkenyne |
IE37602B1 (en) * | 1971-05-11 | 1977-08-31 | Ici Ltd | Cyclopentane derivatives |
US4024179A (en) * | 1972-11-08 | 1977-05-17 | Pfizer Inc. | Substituted ω-pentanorprostaglandins |
-
1972
- 1972-05-10 US US05/252,030 patent/US4304907A/en not_active Expired - Lifetime
-
1973
- 1973-04-30 AU AU55006/73A patent/AU470415B2/en not_active Expired
- 1973-05-02 GB GB379175A patent/GB1409843A/en not_active Expired
- 1973-05-02 GB GB2091873A patent/GB1409841A/en not_active Expired
- 1973-05-02 GB GB379075A patent/GB1409842A/en not_active Expired
- 1973-05-05 DE DE2322673A patent/DE2322673A1/de not_active Withdrawn
- 1973-05-09 FR FR7316720A patent/FR2184007B1/fr not_active Expired
- 1973-05-09 NL NL7306462A patent/NL7306462A/xx not_active Application Discontinuation
- 1973-05-10 BE BE130979A patent/BE799372A/xx not_active IP Right Cessation
- 1973-05-10 CH CH668973A patent/CH585711A5/xx not_active IP Right Cessation
- 1973-05-10 CH CH584176A patent/CH585712A5/xx not_active IP Right Cessation
- 1973-12-19 US US05/426,058 patent/US4303796A/en not_active Expired - Lifetime
-
1977
- 1977-02-07 US US05/766,010 patent/US4116988A/en not_active Expired - Lifetime
- 1977-02-07 US US05/765,997 patent/US4087616A/en not_active Expired - Lifetime
- 1977-02-07 US US05/766,011 patent/US4116989A/en not_active Expired - Lifetime
- 1977-02-07 US US05/765,919 patent/US4096335A/en not_active Expired - Lifetime
- 1977-02-10 US US05/767,443 patent/US4096178A/en not_active Expired - Lifetime
- 1977-02-10 US US05/767,444 patent/US4096179A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
GB1409841A (en) | 1975-10-15 |
US4087616A (en) | 1978-05-02 |
AU5500673A (en) | 1974-10-31 |
US4304907A (en) | 1981-12-08 |
AU470415B2 (en) | 1976-03-18 |
US4303796A (en) | 1981-12-01 |
FR2184007B1 (xx) | 1979-01-12 |
US4116989A (en) | 1978-09-26 |
CH585711A5 (xx) | 1977-03-15 |
US4096178A (en) | 1978-06-20 |
BE799372A (fr) | 1973-11-12 |
GB1409842A (en) | 1975-10-15 |
US4116988A (en) | 1978-09-26 |
FR2184007A1 (xx) | 1973-12-21 |
GB1409843A (en) | 1975-10-15 |
NL7306462A (xx) | 1973-11-13 |
DE2322673A1 (de) | 1973-11-22 |
US4096335A (en) | 1978-06-20 |
US4096179A (en) | 1978-06-20 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |